2021
DOI: 10.3389/fphar.2021.751487
|View full text |Cite
|
Sign up to set email alerts
|

Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System

Abstract: Atherosclerotic cardiovascular disease and subsequent heart failure threaten global health and impose a huge economic burden on society. MicroRNA-132 (miR-132), a regulatory RNA ubiquitously expressed in the cardiovascular system, is up-or down-regulated in the plasma under various cardiac conditions and may serve as a potential diagnostic or prognostic biomarker. More importantly, miR-132 in the myocardium has been demonstrated to be a master regulator in many pathological processes of ischemic or nonischemic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 102 publications
0
6
0
Order By: Relevance
“…The regulatory effect of miR-132 in the oxidative stress pathway in viral infection proposed in our study has yet to be studied. The involvement of miR-132 in oxidative stress has been confirmed in other diseases ( Wasik et al, 2017 ; Zhou et al, 2020 ; Xu et al, 2021 ). Our studies suggested that miR-132 can be involved in tissue damage during L. europaeus infection.…”
Section: Discussionmentioning
confidence: 84%
“…The regulatory effect of miR-132 in the oxidative stress pathway in viral infection proposed in our study has yet to be studied. The involvement of miR-132 in oxidative stress has been confirmed in other diseases ( Wasik et al, 2017 ; Zhou et al, 2020 ; Xu et al, 2021 ). Our studies suggested that miR-132 can be involved in tissue damage during L. europaeus infection.…”
Section: Discussionmentioning
confidence: 84%
“…There are a number of differences between the time of serum level change and clinical significance. Thus, while miR-1, miR-132, miR-133, and miR-373-3-p suggest the concomitant presence of CAD and Type 2 diabetes, the increase in serum miR-92a levels in diabetic patients occurs independently of coronary artery involvement [112,113]. Furthermore, miR-122-5p and miR-223-3p are upregulated in patients with unstable CAD and may be considered a marker of atherosclerotic plaque vulnerability [114,115].…”
Section: Biomarkers Of Destabilization Of Atherosclerotic Plaque-micr...mentioning
confidence: 99%
“…The miRNAs discussed in this section are listed in the following Table 3. [250,251] miR-132 Up-regulated I/R injury in mice [259] Hindlimb ischemia in mice [260] TAC-induced cardiac hypertrophy in mice [261,262] FOXO3a [266] SIRT1 [266] PTEN [266] Down-regulated FOXO3a-mediated expression of antioxidant genes such as MnSOD and CAT [103,104] Suppressed deacetylation of FOXO3a, down-regulating antioxidant response [107] Suppressed FOXO-mediated antioxidant gene expression [115] Down-regulated MI in rats [263,264] and mice [265] Up-regulated MI in mice [268] and rats [269] SOD1 [270] Decreased enzymatic removal of superoxide by SOD [240] Down-regulated MI in rats [267] H/R injured CMs [267] miR-214 Up-regulated MI in mice [271,272] and rats [273] I/R injury in mice [274] AAC-induced cardiac hypertrophy in rats [275] 7 IOS induced cardiac fibrosis in rats [278,279] 7 ME2 [271] Decreased NADPH, increased ROS [282] Down-regulated AngII-induced cardiac fibrosis in mice [280] 8 GSR [283] Decreased GSR-mediated conversion of GSSG into GSH [284] 1 Glutamate cysteine ligase catalytic, 2 Glutamate-cystein ligase, 3 Glutathion, 4 Glucose-6-phosphate dehydrogenase, 5 Pentose phosphate pathway, …”
Section: Mir-214mentioning
confidence: 99%